<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H961FD2A5D3B2405A93CC8493277C92C3" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 4922 IH: Stopping Overdoses of Fentanyl Analogues Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-02-05</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 4922</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20180205">February 5, 2018</action-date><action-desc><sponsor name-id="S000244">Mr. Sensenbrenner</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the <committee-name committee-id="HJU00">Committee on the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to list fentanyl analogues as schedule I controlled
			 substances.</official-title></form>
	<legis-body id="H53BC5BAE53A64C49878787FED73E773A" style="OLC">
 <section id="H8CB99A1B4A4B4C6BB422735AB389F3DE" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Stopping Overdoses of Fentanyl Analogues Act</short-title></quote>.</text> </section><section id="H653CE49109EE4A69A86428E1743B43DA"><enum>2.</enum><header>Fentanyl Analogues</header><text display-inline="no-display-inline">Section 202(c) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/812">21 U.S.C. 812</external-xref>) is amended—</text>
 <subsection id="H5073E864D05345AD8077A4DA96A911F8"><enum>(a)</enum><text display-inline="yes-display-inline">by adding at the end of subsection (b) of Schedule I the following:</text> <quoted-block display-inline="no-display-inline" id="H1A66A2731EC94CC79B1C5588C4261C78" style="OLC"> <paragraph id="H1A00348D5010482E8F037ED30845BAAA"><enum>(23)</enum><text>Acetyl fentanyl 4-methylphenethyl.</text>
 </paragraph><paragraph id="H6B2440347BDD42FE8F3647B5DC30DE28"><enum>(24)</enum><text>Acrylfentanyl.</text> </paragraph><paragraph id="H90ED74B4EE98474F870217C19FE4DD74"><enum>(25)</enum><text>4-fluorobutyrylfentanyl.</text>
 </paragraph><paragraph id="H6EDD80F594184560B70BDD37D815D2FD"><enum>(26)</enum><text>4-fluoroisobutyryl fentanyl.</text> </paragraph><paragraph id="HB9D0C9370D23487ABE8D332DE8E58A36"><enum>(27)</enum><text>3-furanyl fentanyl.</text>
 </paragraph><paragraph id="HE8E905F2778A44FBB6C220026AC02084"><enum>(28)</enum><text>Isobutyryl fentanyl.</text> </paragraph><paragraph id="HFB894EB7E46045A6AA0AAD33E056CC5F"><enum>(29)</enum><text>Meta-fluorofentanyl.</text>
 </paragraph><paragraph id="H871012C8CDFA4690BA6AA37C7FC98B57"><enum>(30)</enum><text>Methoxyacetyl fentanyl.</text> </paragraph><paragraph id="HB202CA54837943E0B5EA1F736FB21B20"><enum>(31)</enum><text>4-methoxybutyrfentanyl.</text>
 </paragraph><paragraph id="H49C39BB81BD04868BCBD2ED8C01F6764"><enum>(32)</enum><text>Ocfentanil.</text> </paragraph><paragraph id="H0F37F1297DD34130B91C5361056D3F1C"><enum>(33)</enum><text>Ortho-fluorofentanyl.</text>
 </paragraph><paragraph id="H261792D8602A4FCF956C88C05F1B0416"><enum>(34)</enum><text>Tetrahydrofuranyl fentanyl.</text> </paragraph><paragraph id="H66F0CB2A6E1C456FA3FFA8D96F9A8B39"><enum>(35)</enum><text>Valeryl fentanyl.</text></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block>
 </subsection><subsection id="HEAB5D722D1A24E7EAFB05C5DEB0C97D8"><enum>(b)</enum><text>by adding at the end of Schedule I the following:</text> <quoted-block display-inline="no-display-inline" id="H99758C6D64644CE9B7F44352BC421EF1" style="OLC"> <subsection id="H70C5A3B0624346EC961C94CF0C1308D2"><enum>(e)</enum> <paragraph commented="no" display-inline="yes-display-inline" id="H51E73AD4DC134165ACFFEBBC80429697"><enum>(1)</enum><text>Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl analogues, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.</text>
 </paragraph><paragraph id="H5B68A7DC8A4B4D8BB585395E096D2E84" indent="up1"><enum>(2)</enum><text>In paragraph (1), the term <term>fentanyl analogues</term> includes any compound structurally derived from fentanyl—</text> <subparagraph id="HFC49D5A5CCFA429CBF4A46C5EE99BFF2"><enum>(A)</enum><text>by replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;</text>
 </subparagraph><subparagraph id="HB6FAEB81F47E45A49BDB8598D96502B0"><enum>(B)</enum><text>by substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups;</text>
 </subparagraph><subparagraph id="HB6C448087E8C42A9BF3A1682283F83E9"><enum>(C)</enum><text>by substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups;</text>
 </subparagraph><subparagraph id="HEF85D32CDA8D4BF8A0A35D566AC6B4A8"><enum>(D)</enum><text>by replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or</text>
 </subparagraph><subparagraph id="HCF307B9D4F7C433DBA23BBB3E42C7834"><enum>(E)</enum><text>by replacement of the N-propionyl group by another acyl group.</text></subparagraph></paragraph></subsection><after-quoted-block>. </after-quoted-block></quoted-block> </subsection></section></legis-body></bill> 

